Clinical trial
Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations: A Multicenter, Prospective, Diagnostic Clinical Cohort Study.
NCT06041009 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations: A Multicenter, Prospective, Diagnostic Clinical Cohort Study.
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 5, 2023
- Completion date
- September 30, 2025
- Enrollment
- 2,100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic diseases, pancreatic ductal adenocarcinoma, pancreatic elastase 1, pancreatic neoplasms, pancreatic neuroendocrine tumor, pancreatitis